RA患者ACPA亚组间炎症消退时间顺序不同提示潜在炎症通路差异
该研究对216例RA或未分化关节炎患者(均起始csDMARD治疗)在基线及4、12、24个月行1.5T增强手足MRI,采用交叉滞后模型分析炎症特征消退的时间模式。结果显示所有炎症特征配对在各时间间期均同时下降,滑膜炎消退先于腱鞘炎消退;ACPA阳性患者中滑膜炎消退先于骨炎消退,而ACPA阴性患者无此现象,提示ACPA亚组间潜在炎症通路存在差异。
要点
- 所有炎症特征配对在0-4、4-12、12-24个月间期均同时下降。
- 滑膜炎消退先于腱鞘炎消退(0-4至>4-12个月P=0.02;4-12至>12-24个月P=0.03)。
- ACPA阳性患者中滑膜炎消退先于骨炎消退(4-12至>12-24个月P=0.002),ACPA阴性者无此现象。
核心结论
- 除炎症同时下降外,滑膜炎消退先于腱鞘炎消退。
- ACPA亚组间炎症消退时间顺序的差异提示潜在炎症通路不同。
研究设计与样本
- 连续纳入216例RA(n=176)或未分化关节炎(n=40)患者,均起始csDMARD治疗。
- 在治疗前及治疗后4、12、24个月行1.5T增强手和足MRI。
- 采用交叉滞后模型评估同时模式和后续模式,并进行ACPA分层。
主要发现
- 所有炎症特征配对在所有时间间期(0-4/4-12/12-24个月)均同时下降(P<0.05)。
- 滑膜炎消退先于腱鞘炎消退(0-4至>4-12个月P=0.02;4-12至>12-24个月P=0.03)。
- 两个ACPA亚组结果基本相似。
- ACPA阳性但非ACPA阴性患者中,滑膜炎消退先于骨炎消退(4-12至>12-24个月P=0.002)。
临床怎么用
- MRI可用于在组织水平理解RA患者对DMARD治疗的反应顺序。
- ACPA状态可能提示不同的潜在炎症通路,影响炎症消退的时间顺序。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Advanced imaging modalities have shown that not only joints but also bones and tendon sheaths can be inflamed at diagnosis of RA. We aimed to better understand the time-order in which the inflamed tissues respond to DMARD treatment. Also, because ACPA status may reflect a different pathophysiology, differences in time-order of inflammation decrease were hypothesized between these disease types. METHODS: A total of 216 consecutive patients presenting with RA (n = 176) or undifferentiated arthritis (n = 40), who all started with conventional synthetic DMARD treatment, were studied. 1.5T contrast-enhanced hand and foot MRIs were performed before treatment and after 4, 12 and 24 months. Cross-lagged models evaluated the influence of two time patterns: a simultaneous pattern ('change in one inflammatory feature associated with change in another feature') and a subsequent pattern ('change in one inflammatory feature preceded change in another feature'). ACPA stratification was performed. RESULTS: The median symptom duration at presentation was 13 weeks. Forty-four percent of patients was ACPA-positive. All pairs of inflammatory features decreased simultaneously in all time intervals (0-4/4-12/12-24 months; P < 0.05). Moreover, time-orders were identified: synovitis decrease preceded tenosynovitis decrease (0-4 to >4-12 months; P = 0.02 and 4-12 to >12-24 months; P = 0.03). Largely similar results were obtained in both ACPA subgroups. Additionally, in ACPA-positive but not ACPA-negative patients, synovitis decrease preceded osteitis decrease (4-12 to >12-24 moths; P = 0.002). CONCLUSION: This study increased the understanding of the response to treatment on the tissue level. In addition to simultaneous decrease of inflammation, synovitis decrease preceded tenosynovitis decrease. Differences in time-order of inflammation decrease between ACPA subgroups suggest differences in underlying inflammatory pathways.
引用
- Matthijssen XME, Niemantsverdriet E, Le Cessie S, et al. Differing time-orders of inflammation decrease between ACPA subsets in RA patients suggest differences in underlying inflammatory pathways. Rheumatology (Oxford). 2021. PMID: 33164106. doi:10.1093/rheumatology/keaa658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。